key: cord-0940685-3kyeyclt
authors: Mackay, Ian M.; Lambert, Stephen B.; McErlean, Peter K.; Faux, Cassandra E.; Arden, Katherine E.; Nissen, Michael D.; Sloots, Theo P.
title: Prior Evidence of Putative Novel Rhinovirus Species, Australia
date: 2008-11-03
journal: Emerg Infect Dis
DOI: 10.3201/eid1411.080725
sha: 3254a59b4e4197c623810ccd9cb9b49b266abb04
doc_id: 940685
cord_uid: 3kyeyclt

nan

To the Editor: Briese et al. (1) are to be congratulated for their delineation of the global geographic presence of human rhinovirus (HRV) strains similar to those reported in 2006 from one third of cases of an otherwise pathogen-negative respiratory outbreak in New York. Of equal importance is the temporal occurrence of these strains. Although it is intriguing to suggest, on the basis of limited sequence data, that these strains were circulating at least 2 centuries earlier (1), Briese et al. neglect to acknowledge empirical evidence that what we now call HRV-C strains circulated before 2004-2005. Unculturable PCR-positive rhinoviruses were reported in 1993; however, more compelling is the fact that subgenomic sequence and phylogenetic data were reported from Belgium (2), Australia (3), and then New York (4). The Belgium noncoding sequences were reported in 2006 but originated from specimens collected in 1998-1999. Australian coding sequences from 2003 to 2004 were assigned, for the fi rst time, to a novel clade called HRV-A2, refl ecting both their phylogenetic isolation and branching from the known HRV-A strains (3) .

It can be deduced that NY-041 and NY-060, strains from the 2004 New York winter outbreak, are variants (>98% amino acid identity) of the fi rst characterized HRV-A2 strain, HRV-QPM (4,5). More recently, we proposed that the HRV-A2 strains diverged suffi ciently to meet several of the International Committee on Taxonomy of Viruses criteria for classifying a putative new species, HRV-C (6).

It is an exciting time for those interested in rhinoviruses. With increased implementation of multiplexed screening approaches (such as the MassTag PCR), or by simply including a specifi c and sensitive PCR for all known strains (7), further details of the geographic and temporal extent of the neglected rhinoviruses should soon be available. Better identifi cation may fi nally enable accurate characterization of the clinical, economic, and social impact (8) In Response: We appreciate the enthusiasm for our recent publication highlighting the global distribution of a long-unrecognized third clade of rhinoviruses. Robust, sequence-based clock estimates with associated confidence limits indicate that these viruses have been circulating for hundreds of years (1), consistent with the presence of such viruses in historic samples. As isolates from various collections are analyzed in informative regions (e.g., virus protein [VP] 4/2 or VP1), we will undoubtedly fi nd examples in which human rhinoviruses (HRVs) could have been classifi ed as members of the new species HRV-C but were not because the characteristics that defi ne HRV-C were not yet appreciated or because only noncoding sequences had been analyzed. Indeed, we anticipate that waxing interest in HRVs may well lead to the discovery of additional clades.

There has been discussion in the fi eld as to whether the novel sequences represent a sublineage HRV-A2 of the classifi ed species HRV-A (2,3), as Mackay et al. had proposed, or whether they should be considered as representatives of a third species of HRV (4,5). The International Committee on Taxonomy of Viruses (ICTV) is charged with the recognition and naming of taxonomic entities. Thus, we provisionally designated our sequences as a novel clade distinct from HRV-A and HRV-B (4) and submitted a proposal to ICTV with data supporting the recognition of HRV-C as a third species of rhinovirus. The proposal was recently approved by the ICTV Study Group on Picornaviruses (Europic May 2008 meeting in Sitges, Spain). Irrespective of taxonomic discourse, we agree with Mackay and colleagues that molecular analyses of as-yet-uncultured HRVs are fascinating and have potential to reveal unexpected insights into the role of HRVs in disease.

In Forest Fragmentation as Cause of Bacterial Transmission among Primates, Humans, and Livestock, Uganda (T.L. Goldberg et al.), 2 errors occurred. In Table 3 , the numerical values are not in the right positions. The corrected table is available from www.cdc.gov/EID/content/14/09/1375-T3.htm. In the same article, Figures 3 and 4 were inadvertently reversed. This has also been corrected in the online version of the article (available from www.cdc.gov/EID/content/14/9/1375.htm). We regret any confusion these errors may have caused. In the circles, the individual isolates are mentioned. The numbers between the circles represent the summed tandem repeat differences (STRDs) between multiple-locus variablenumber tandem-repeat analysis types. Straight lines represent single-locus variants, dashed lines double-locus variants. Curved lines represent triplelocus variants. Two related clusters can be discriminated: the light gray cluster (isolates B1, B4, M246, B6, and M216) and the cluster within dotted lines (isolates V6-44, V6-142, V6-81, 1ML, C1, 4108, V6-35, V6-80, L1, 2191cc, C4, C8, 3ML, C44, C37, and 13ML) The isolates in the light gray cluster are sensitive to clindamycin; isolates in the cluster surrounded by dashed lines are resistant. Two isolates (M278 and R20291) did not belong to a cluster but were more related to the sensitive cluster than to the resistant cluster. Genetically related clusters were defi ned by an STRD <10.

Global distribution of novel rhinovirus genotype

Characterisation of a newly identifi ed human rhinovirus, HRV-QPM, discovered in infants with bronchiolitis

A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants

MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused infl uenza-like illness